# T2* MRI Analysis for Sarcoma

> **NCT03658343** · — · COMPLETED · sponsor: **Bryan Allen** · enrollment: 8 (actual)

## Conditions studied

- Radiotherapy
- Magnetic Resonance Imaging
- Sarcoma

## Interventions

- **DIAGNOSTIC_TEST:** T2* Imaging

## Key facts

- **NCT ID:** NCT03658343
- **Lead sponsor:** Bryan Allen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-18
- **Primary completion:** 2022-02-25
- **Final completion:** 2022-02-25
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-02-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03658343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03658343, "T2* MRI Analysis for Sarcoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03658343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*